Global Disparities in HTLV-1 Research and Response: A Unique Focus on U.S. Afro-Caribbean and Polynesian/Japanese Populations
Pathogens · 17.11.2026 · 15 (11) · 1206
DOI: 10.3390/pathogens15111206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 17.11.2026. Verfasst von Ryan Hoffmann und 5 weiteren Autor:innen. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: InterConsortium (Drexel/Jefferson) Pilot Funding through the NCI-accredited Sydney Kimmel Comprehensive Cancer Center, National Institutes of Health (NIH)/NINDS.
Abstract (Originalsprache)
Human T-cell leukemia virus type 1 (HTLV-1) is a neglected retrovirus that causes adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Despite an estimated 5–10 million worldwide infections, surveillance remains limited, particularly among underserved United States (U.S.) populations. This report examines disparities in HTLV-1 research, diagnosis, and care across populations from endemic regions and their U.S. diasporas. Jamaica, Haiti, and Trinidad & Tobago report seroprevalence rates of 1–6%, yet surveillance has declined since the early 2000s. Elevated ATLL incidence among Caribbean-born U.S. residents indicates substantial disease burden despite the absence of population-based HTLV-1 surveillance. Japan’s national antenatal screening programs have reduced transmission, while the United States lacks comparable frameworks. HTLV-1 prevalence among U.S. Pacific Islander populations remains insufficiently characterized, and demographic aggregation limits population assessment. Limited surveillance and barriers to diagnosis leave important uncertainties about the distribution of HTLV-1 infection and associated disease in the United States; ancestry and demographic concentration alone cannot resolve these uncertainties. Drawing on international experience, this report proposes integrating low-cost diagnostics, community-led outreach, and equitable clinical trial participation to improve detection and outcomes. HTLV-1 thus represents not only an infectious disease gap but a marker of enduring global and domestic health inequities.
Förderung
- InterConsortium (Drexel/Jefferson) Pilot Funding through the NCI-accredited Sydney Kimmel Comprehensive Cancer Center
- National Institutes of Health (NIH)/NINDS
Zitieren
APA
Hoffmann, R., MacNary, C. A., Sawney, S., Reilly, S. P., Pinheiro, P., & Jain, P. (2026). Global Disparities in HTLV-1 Research and Response: A Unique Focus on U.S. Afro-Caribbean and Polynesian/Japanese Populations. Pathogens, 15(11), 1206. https://doi.org/10.3390/pathogens15111206
Vancouver
Hoffmann R, MacNary CA, Sawney S, Reilly SP, Pinheiro P, Jain P. Global Disparities in HTLV-1 Research and Response: A Unique Focus on U.S. Afro-Caribbean and Polynesian/Japanese Populations. Pathogens. 2026;15(11):1206. doi:10.3390/pathogens15111206
BibTeX
@article{Hoffmann2026,
author = {Hoffmann, Ryan and MacNary, Catherine A. and Sawney, Shari and Reilly, Sean P. and Pinheiro, Paulo and Jain, Pooja},
title = {Global Disparities in HTLV-1 Research and Response: A Unique Focus on U.S. Afro-Caribbean and Polynesian/Japanese Populations},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {11},
pages = {1206},
doi = {10.3390/pathogens15111206}
}
EUVIMED